Regions: Europe, Middle East, Africa

Arnstein Arnebergsvei 30
1366 Lysaker
Norway
+47 40 00 42 79

E-mail: mail@calpro.no

Regions: North America, Central and South America, Southeast Asia, Asia

10650 Scripps Ranch Blvd., Suite 105
San Diego, CA 92131
United States
+1 858 578 7660
+1 858 578 7447 Fax

E-mail: mail@calpro.no
E-mail: jfewster@calpro.no
E-mail: adminusa@calpro.no

Calprotectin - a direct and non invasive marker of intestinal inflammation.

PhiCal ELISA Test is a validated and FDA approved assay system for the determination of calprotectin in stool extracts.

• Reliable tool to differentiate between IBD and IBS
• Assessment of inflammation activity in IBD
• Monitoring response to treatment in IBD
• Assessment of mucosal healing in IBD
• Predictor of relapses in IBD

PhiCal Test (Calprest) is a quantitative enzyme-linked immunoassay (ELISA) for detection of increased concentrations of calprotectin in plasma, cerebrospinal fluid, synovial fluid, urine or stools as a consequence of disease in relevant organs. During septicaemia, plasma calprotectin levels will rise more rapidly than C-reactive protein since increased synthesis of the latter by the liver takes time, while calprotectin is pre-formed in the leukocytes. (personal observations)

Keywords of special interest: PhicalTest, Calpro, Calprotectin